A STUDY OF NEW SPECIES OF GIN BERRY (GLYCOSMIS ALBICARPA): A REIVEW
PADMAXI BAILPATTAR SHRISHAILAPPA BADAMI NAYANABHIRAM UDUPA
Abstract:-
The present article is a systematic and constructive review of various species of Glycosmis and emphasizing of new species of gin berry that is Glycosmisalbicarpa. The genus Glycosmis comprise 51 accepted species broadly distributed in Australia, China, India, and South-East Asia. Traditionally, Glycosmis species are used in folk medicines to treat cancer, anaemia, rheumatism, fever, cough, liver-related problems, skin ailments, intestinal worm infections, wounds, and facial inflammation. 307 chemical constituents have been isolated and characterized from different species of the genus Glycosmis; among these constituents, alkaloids, flavonoids, terpenoids, phenolics, and sulphur-containing amides are the major bioactive compounds. This review aims to provide readers with the latest information highlighting on new species of Glycosmis, its habitat, features, and uses of Glycosmisalbicarpa. Detail review of Pharmacological, toxicological and morphological study of Glycosmisalbicarpa is yet to be scrutinized. So that study of this new species can be advancement in Pharmaceutical industry for formulation of various dosage forms for treatment of various ailments. The recent discovery is the new species of Gin Berry which was found in India (kanyakumari wildlife sanctuary) and reported on 5th march 2022 in the newspaper (The HINDU).